LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 86.16 | 84.90 | 5399 | 8141 | 0.6631 | 0.8790 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 86.16 | 84.90 | 169 | 8141 | 0.0208 | 0.1102 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 86.16 | 84.90 | 4019 | 8141 | 0.4936 | 0.7966 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 86.16 | 84.90 | 4992 | 8141 | 0.6131 | 0.8568 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 86.16 | 84.90 | 5328 | 8141 | 0.6544 | 0.8752 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 87.86 | 84.90 | 54 | 7680 | 0.0070 | -0.0672 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 87.86 | 84.90 | 5542 | 7680 | 0.7216 | 0.9021 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 87.86 | 84.90 | 136 | 7680 | 0.0177 | 0.0752 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 87.86 | 84.90 | 4157 | 7680 | 0.5413 | 0.8197 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 87.86 | 84.90 | 5020 | 7680 | 0.6536 | 0.8733 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 87.86 | 84.90 | 5462 | 7680 | 0.7112 | 0.8978 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 89.57 | 84.90 | 53 | 7494 | 0.0071 | -0.0703 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 89.57 | 84.90 | 5631 | 7494 | 0.7513 | 0.9135 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 89.57 | 84.90 | 135 | 7494 | 0.0180 | 0.0744 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 89.57 | 84.90 | 4215 | 7494 | 0.5624 | 0.8296 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 89.57 | 84.90 | 5283 | 7494 | 0.7049 | 0.8947 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 89.57 | 84.90 | 5608 | 7494 | 0.7483 | 0.9123 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 91.27 | 84.90 | 53 | 7420 | 0.0071 | -0.0704 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 91.27 | 84.90 | 5787 | 7420 | 0.7799 | 0.9244 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 91.27 | 84.90 | 111 | 7420 | 0.0150 | 0.0424 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 91.27 | 84.90 | 4317 | 7420 | 0.5818 | 0.8389 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 91.27 | 84.90 | 5128 | 7420 | 0.6911 | 0.8886 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 91.27 | 84.90 | 5724 | 7420 | 0.7714 | 0.9211 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 92.98 | 84.90 | 73 | 7257 | 0.0101 | -0.0233 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 92.98 | 84.90 | 5961 | 7257 | 0.8213 | 0.9396 | MN20160318_Q02 | H19 |